Acne

Related records

Broader conditions (14)

• Dermatitis
• Disease
• Disease by body system or component
• Disease by developmental or physiological process
• Disease by etiologic mechanism
• Disease of genetic or genomic mechanism
• Disorder of pilosebaceous unit
• Hereditary disease
• Hereditary skin disorder
• Human disease
• Inflammatory disease
• Integumentary system disorder
• Sebaceous gland disorder
• Skin disorder

Narrower conditions (1)

• Adult acne

Trials (769)

• "A Comparative Clinical Evaluation of the Efficacy of Topical Adapalene, Benzoyl Peroxide Gel, Oral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin Capsule, and Their Fixed Combination in Mild to Moderate Acne Vulgaris Patients."
• "A Randomized, Controlled, Evaluator-blinded Pilot Study to Evaluate the Effect of Automated Text Message Reminders on Patient Compliance With Topical Medications and Its Efficacy on Skin Disease Control in Adolescents and Adults With Mild to Moderate Acne"
• "Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy"
• 1% Clascoterone Cream for the Treatment Acne Vulgaris
• 2940nm Er:YAG Laser Versus Benzoyl Peroxide Gel for the Treatment of Inflammatory Acne
• 5% Sodium L-Ascorbyl-2-Phosphate Lotion for the Treatment of Acne Vulgaris
• 577-nm Diode Laser in the Treatment of Non -Inflammatory Acne
• 8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne
• A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris
• A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris
• A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris
• A Botanical Skin Care Regimen on Mild to Moderate Acne and the Microbiome
• A Clinical Evaluation of Marula-Derived Ceramide Cream on Skin Barrier Function Enhancement
• A Clinical In-Use Evaluation to Assess the Tolerability and Efficacy of a Moisturizer on Acne Prone Skin
• A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris
• A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris
• A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel
• A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash
• A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris
• A Clinical Trial Evaluating the Safety and Efficacy of the KLOX Biophotonic System in Moderate to Severe Acne

Approved drugs (38)

• Adapalene
• Aluminum chloride
• Azelaic acid
• Benzoyl peroxide
• Bithionol
• Chloramphenicol
• Clascoterone
• Clindamycin
• Clindamycin phosphate
• Dapsone
• Dexamethasone
• Doxycycline
• Doxycycline hyclate
• Drospirenone
• Erythromycin
• Ethinyl estradiol
• Fluorometholone
• Folic acid
• Hydroxocobalamin
• Isotretinoin

Drugs in development (57)

• Acebilustat Phase 2
• Adenosine diphosphate Phase 2
• Afamelanotide Phase 2
• Alcohol Phase 2
• Aminolevulinic acid Phase 1
• Aminolevulinic acid hydrochloride Phase 2
• Apremilast Phase 2
• Ascorbic acid Phase 1
• Azithromycin Phase 3
• Berdazimer sodium Phase 3
• Bermekimab Phase 2
• Calcipotriene Phase 2
• Cannabidiol Phase 2
• CJM-112 Phase 2
• Clindamycin hydrochloride Phase 1
• Cyproterone acetate Phase 3
• Denifanstat Phase 3
• Dimethylcurcumin Phase 2
• Finasteride Phase 2
• Gevokizumab Phase 2

Other linked drugs (11)

• Artenimol
• Ciaftalan
• Cyproterone
• Demeclocycline
• Ecalcidene
• Ozenoxacin
• Promestriene
• Riboflavin
• Rolitetracycline
• Sucralfate
• Triamcinolone